Search | OpenScholar

Search results

1964 results found

Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology...

Publication: Journal Article

Connors, JJ, D Sacks, AJ Furlan, WR Selman, EJ Russell, PE Stieg, MN Hadley, RA Hauser, and . 2005. “Training, Competency, and Credentialing Standards for Diagnostic Cervicocerebral Angiography, Carotid Stenting, and Cerebrovascular Intervention: A Joint Statement from the American Academy of Neurology. ”. Neurology.

Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Publication: Journal Article

Zesiewicz, TA, R Elble, ED Louis, RA Hauser, KL Sullivan, RB Dewey, and . 2005. “Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: Therapies for Essential Tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology.”. Neurology.

Positron emission tomography after fetal transplantation in Huntington’s disease. Ann Neurol 2005; 58:331-337.

Publication: Journal Article

Furtado, S, V Sossi, RA Hauser, A Samii, M Schulzer, CB Murphy, TB Freeman, and AJ Stoessl. 2005. “Positron Emission Tomography After Fetal Transplantation in Huntington’s Disease. Ann Neurol 2005; 58:331-337.”. Ann Neurol.

Chorea in a patient with cerebral palsy: treatment with levetiracetam. Movement Disorders 2005;20:762-764.

Publication: Journal Article

Recio, MV, RA Hauser, ED Louis, H Radhashakar, KL Sullivan, and TA Zesiewicz. 2005. “Chorea in a Patient With Cerebral Palsy: Treatment With Levetiracetam. Movement Disorders 2005;20:762-764.”. Movement Disorders.

Initial management of Parkinson’s disease in a Florida community. J Applied Research 2004;4:95-98.

Publication: Journal Article

Zesiewicz, TA, SN Carter, KL Sullivan, JS Staffetti, PB Dunne, and RA Hauser. 2004. “Initial Management of Parkinson’s Disease in a Florida Community. J Applied Research 2004;4:95-98.”. J Applied Research.

Substantial improvement in a Meige's syndrome patient with levetiracetam treatment. Movement Disorders 2004;19:1518-1521.

Publication: Journal Article

Zesiewicz, TA, ED Louis, KL Sullivan, M Menkin, PB Dunne, and RA Hauser. 2004. “Substantial Improvement in a Meige’s Syndrome Patient With Levetiracetam Treatment. Movement Disorders 2004;19:1518-1521.”. Movement Disorders.

Essential tremor. Epidemiology, diagnosis, and treatment. Neurologist 2004;10:250-258.

Publication: Journal Article

Sullivan, KL, RA Hauser, and TA Zesiewicz. 2004. “Essential Tremor. Epidemiology, Diagnosis, and Treatment. Neurologist 2004;10:250-258.”. Neurologist.

Double-blinded, placebo-controlled study of entacapone in levodopa-treated patients with Parkinson disease. Archives of neurology, 61(10), 1563.

Publication: Journal Article

Olanow, CW, K Kieburtz, M Stern, R Watts, JW Langston, M Guarnieri, RA Hauser, and J Hubble. 2004. “Double-Blinded, Placebo-Controlled Study of Entacapone in Levodopa-Treated Patients With Parkinson Disease. Archives of Neurology, 61(10), 1563.”. Archives of Neurology.

Autonomic nervous system dysfunction in Parkinson’s disease. Curr Treat Options Neurol 2003; 5:149-160.

Publication: Journal Article

Zesiewicz, TA, MJ Baker, M Wahba, and RA Hauser. 2003. “Autonomic Nervous System Dysfunction in Parkinson’s Disease. Curr Treat Options Neurol 2003; 5:149-160.”. Curr Treat Options Neurol.

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson’s disease.

Publication: Journal Article

Kase, H, S Aoyama, M Ichimura, K Ikeda, A Ishii, T Kanda, K Koga, and . 2003. “Progress in Pursuit of Therapeutic A2A Antagonists: the Adenosine A2A Receptor Selective Antagonist KW6002: Research and Development Toward a Novel Nondopaminergic Therapy for Parkinson’s Disease.”. Neurology.